Stay updated on Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.3.4 notice was added and the Revision: v3.3.3 notice was removed from the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section with Florida as a site. Removed the old Florida Locations heading and the HHS Vulnerability Disclosure footer; page revision updated to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.3.2 added; Revision: v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding lapse notice was removed from the page. Trial details, eligibility criteria, and study results remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedScreenshots show no substantive changes to the Study Details page for NCT03245736; only minor formatting and layout variations are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

Stay in the know with updates to Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.